LILLY ENDOWMENT INC - 03 Mar 2025 Form 4 Insider Report for ELI LILLY & Co (LLY)

Role
10%+ Owner
Signature
/s/ Diane M. Stenson, Vice President & Treasurer, on behalf of Lilly Endowment Inc.
Issuer symbol
LLY
Transactions as of
03 Mar 2025
Net transactions value
-$204,326,151
Form type
4
Filing time
04 Mar 2025, 16:00:10 UTC
Previous filing
26 Feb 2025
Next filing
25 Jul 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LLY Common Stock Sale $17,367,343 -18,828 -0.02% $922.42 96,218,150 03 Mar 2025 Direct F1
transaction LLY Common Stock Sale $7,567,905 -8,197 -0.01% $923.25 96,209,953 03 Mar 2025 Direct F2
transaction LLY Common Stock Sale $7,086,515 -7,665 -0.01% $924.53 96,202,288 03 Mar 2025 Direct F3
transaction LLY Common Stock Sale $3,416,220 -3,691 -0% $925.55 96,198,597 03 Mar 2025 Direct F4
transaction LLY Common Stock Sale $7,787,962 -8,401 -0.01% $927.03 96,190,196 03 Mar 2025 Direct F5
transaction LLY Common Stock Sale $19,507,205 -21,025 -0.02% $927.81 96,169,171 03 Mar 2025 Direct F6
transaction LLY Common Stock Sale $24,138,720 -25,984 -0.03% $928.98 96,143,187 03 Mar 2025 Direct F7
transaction LLY Common Stock Sale $63,454,661 -68,251 -0.07% $929.72 96,074,936 03 Mar 2025 Direct F8
transaction LLY Common Stock Sale $23,321,552 -25,057 -0.03% $930.74 96,049,879 03 Mar 2025 Direct F9
transaction LLY Common Stock Sale $16,207,093 -17,393 -0.02% $931.82 96,032,486 03 Mar 2025 Direct F10
transaction LLY Common Stock Sale $9,979,706 -10,699 -0.01% $932.77 96,021,787 03 Mar 2025 Direct F11
transaction LLY Common Stock Sale $3,732,139 -3,997 -0% $933.74 96,017,790 03 Mar 2025 Direct F12
transaction LLY Common Stock Sale $759,130 -812 -0% $934.89 96,016,978 03 Mar 2025 Direct F13
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $922.00 to $922.98, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1), (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), and (13) to this Form 4.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $923.00 to $923.98, inclusive.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $924.00 to $924.9905, inclusive.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $925.035 to $926.02, inclusive.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $926.30 to $927.27, inclusive.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $927.34 to $928.31, inclusive.
F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $928.34 to $929.31, inclusive.
F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $929.34 to $930.33, inclusive.
F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $930.34 to $931.33, inclusive.
F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $931.37 to $932.36, inclusive.
F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $932.39 to $933.38, inclusive.
F12 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $933.50 to $934.443, inclusive.
F13 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $934.583 to $935.00, inclusive.